Building a $1 million portfolio is less about chasing the hottest ticker and more about turning reliable signals into a ...

Gossamer Bio advances the Feb. 2026 PROSERA Phase 3 readout for seralutinib in PAH, with expanded endpoints and a new ILD trial. Learn why GOSS stock is a hold.

Cell-sized robots can sense temperature, make decisions, and move autonomously using nanowatts of power—no external control ...

Zhouhighlightedaspecificgame-changerinHainanFTP—apolicyallowinggoodswithatleast30percentvalue-addedproce… ...

There’s a narrative circulating among restaurant brands that’s holding them back: “We’re not a discount brand.” I hear it ...

By committing so many bodies to the offensive glass, the Cavs are leaving themselves vulnerable in transition, forcing guards into impossible recovery duties and exposing a defense that can’t keep up ...

The CBS firefighter drama's dedication to authenticity hit home for several members of its L.A.-based team, with the upcoming midseason finale a poignant look at a grieving family.

Rogue Storm #3 hits stores this Wednesday with an ancient evil, dead sorcerers, and a ghost twin brother. What could go wrong?

Kodiak Sciences has recently completed an upsized underwritten public offering, issuing 6,956,522 shares of common stock at US$23.00 per share to raise roughly US$160.00 million in gross proceeds. The ...

Dilon Technologies, a leading provider of medical devices, has gained FDA approval for its MarginProbe(R) 2 system and is announcing its launch in the U.S. This is the next-generation device for ...

How AI, privacy-preserving computation, and explainable models quietly strengthen payments, protect data, and bridge traditional finance with crypto systems.

New research highlights NVIDIA's AI-driven growth, Netflix's ad-tier momentum and Merck's pipeline progress, while microcaps also make the cut.